Ascendis Pharma logo

Associate Director, Global Medical Writing (Publications) - Job ID: 1983b

Ascendis Pharma

Any City, USRemotePosted 1 day ago$170,000 - $185,000/year
Full TimeDirector & AboveMedical AffairsBiotechnology
Original posting ↗

Summary

The Associate Director, Global Medical Writing (Publications), will be responsible for writing scientific publications connected with Ascendis' clinical trials in endocrine indications. The role involves extensive cross-functional collaboration with internal groups, including Clinical Development, Biostatistics, and Publication Planning, and with external investigators and researchers.

Job description

Key Responsibilities

  • Draft, revise, and edit scientific publications, including manuscripts for peer-reviewed journals as well as abstracts, posters, and oral presentations for medical conferences.
  • Collaborate with Publication Planning team to coordinate kick-off calls with Investigators and establish timelines for the development of publications.
  • Work with internal stakeholders to ensure publications are clear, accurate, and aligned with strategic goals.
  • Participate in meetings with clinical trial investigators and key opinion leaders for the review and revision of drafts and to manage the editing and revision process, ensuring timely completion of scientific publications.
  • Keep current with the latest information, trends, and developments in target therapy areas, and perform literature searches as needed for drafting publications. Interpret literature information relevant to scientific publications. Understand, assimilate, and interpret data and other sources of information with appropriate guidance/direction from authors and therapeutic teams.
  • Remain current on industry and company requirements and best practices as they relate to scientific publications.
  • Understand and follow applicable company publication policy and procedures and act as a subject matter expert regarding internal processes and relevant publication guidelines.

Qualifications

  • MS/PhD/PharmD or 8+ years of experience writing scientific publications. Professional credentials/certification (e.g., CMPP) a plus.
  • Familiarity with endocrinology and/or rare disease is a benefit but not required.
  • Understanding of US and international regulations, requirements, and guidance associated with scientific publications (ICMJE, Good Publication Practice, etc).
  • Ability to work directly from data outputs and clinical documents (protocols, CSRs, etc) to draft.
  • Excellent communication skills and attention to detail; ability to assimilate and interpret scientific content and translate information for appropriate audiences.

Requirements

  • MS/PhD/PharmD or 8+ years of experience writing scientific publications
  • Professional credentials/certification (e.g., CMPP) a plus
  • Familiarity with endocrinology and/or rare disease is a benefit but not required
  • Understanding of US and international regulations, requirements, and guidance associated with scientific publications (ICMJE, Good Publication Practice, etc)
  • Ability to work directly from data outputs and clinical documents (protocols, CSRs, etc) to draft
  • Excellent communication skills and attention to detail
  • Ability to assimilate and interpret scientific content and translate information for appropriate audiences

Benefits

  • 401(k) Matching
  • Medical, Dental & Vision
  • Life & AD&D Insurance
  • Short & Long-Term Disability
  • Pet Insurance
  • Legal Insurance
  • Employee Assistance Program
  • Employee Discounts
  • Professional Development
  • Health Saving Account (HSA)
  • Flexible Spending Accounts
  • Incentive Compensation Plans
  • Accident, Critical Illness & Hospital Indemnity
  • Mental Health Resources
  • Paid Parental Leave
  • Paid Time Off
  • Discretionary Annual Bonus
  • Stock-Based Long-Term Incentives

Company overview

Ascendis Pharma is a global biopharmaceutical company founded in 2007 and headquartered in Hellerup, Denmark, with additional facilities across Europe and the United States. The company is publicly traded on Nasdaq under the symbol ASND. Ascendis Pharma specializes in applying its innovative TransCon technology platform to develop novel therapies that address unmet medical needs in endocrinology rare diseases and oncology. The company's core values of Patients, Science, and Passion guide its mission to create potentially best-in-class therapies. Ascendis has two marketed products: SKYTROFA (lonapegsomatropin-tcgd) for pediatric growth hormone deficiency and YORVIPATH (palopegteriparatide) for adult hypoparathyroidism. The company's pipeline includes TransCon CNP for achondroplasia and oncology candidates like TransCon TLR7/8 Agonist and TransCon IL-2 β/γ. With approximately 1,017 employees globally as of December 2024, Ascendis operates through a combination of direct commercialization in key markets and strategic partnerships in regions like Greater China and Japan through VISEN Pharmaceuticals and Teijin Limited, respectively.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.